Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
WSFS Financial | WSFS | Nov 21, 2024 | 58.71 | +2.10 |
WW International | WW | Nov 21, 2024 | 1.01 | +6.32 |
Wyndham Hotels & Resorts | WH | Nov 21, 2024 | 96.39 | +1.78 |
Wynn Resorts | WYNN | Nov 21, 2024 | 91.74 | +0.57 |
X Financial A ADR | XYF | Nov 21, 2024 | 6.25 | 0.00 |
X3 Holdings | XTKG | Nov 21, 2024 | 0.11 | +20.00 |
X4 Pharmaceuticals | XFOR | Nov 21, 2024 | 0.37 | +8.23 |
XAI Octagon Floating Rate & Alternative Income Term Trust | XFLT | Nov 21, 2024 | 6.90 | +0.15 |
XAI Octagon Floating Rate & Alternative Income Term Trust 20 | XFLT-A | Nov 21, 2024 | 25.16 | +0.04 |
XBiotech | XBIT | Nov 21, 2024 | 6.62 | +2.00 |
XBP Europe | XBP | Nov 21, 2024 | 1.26 | -3.82 |
Xcel Brands | XELB | Nov 21, 2024 | 0.70 | -1.43 |
Xcel Energy | XEL | Nov 21, 2024 | 71.38 | +1.90 |
XChange Tec.Inc ADR | XHG | Nov 21, 2024 | 1.50 | +3.45 |
XCHG Limited - ADS | XCH | Nov 21, 2024 | 14.70 | 0.00 |
Xencor | XNCR | Nov 21, 2024 | 24.10 | +1.60 |
Xenetic Biosciences | XBIO | Nov 21, 2024 | 4.01 | +0.57 |
Xenia Hotels & Resorts | XHR | Nov 21, 2024 | 15.02 | +1.76 |
Xenon Pharmaceuticals | XENE | Nov 21, 2024 | 39.80 | +1.17 |
Xeris Biopharma | XERS | Nov 21, 2024 | 3.04 | -0.65 |
Xerox | XRX | Nov 21, 2024 | 8.75 | +4.29 |
XIAO-I ADR | AIXI | Nov 21, 2024 | 5.80 | +6.23 |
Xilio Therapeutics | XLO | Nov 21, 2024 | 0.92 | -2.25 |
Xinyuan Real Estate ADR | XIN | Nov 21, 2024 | 3.22 | -8.26 |
XOMA | XOMA | Nov 21, 2024 | 30.07 | +0.17 |
XOMA A Pref | XOMAP | Nov 21, 2024 | 25.69 | 0.00 |
XOMA B Pref | XOMAO | Nov 21, 2024 | 25.33 | -0.04 |
Xometry A | XMTR | Nov 21, 2024 | 31.07 | +4.79 |
XORTX Therapeutics | XRTX | Nov 21, 2024 | 1.26 | +0.40 |
Xos | XOS | Nov 21, 2024 | 4.06 | +5.11 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.